posted on
Aug 05, 2021 02:14PM

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Message: The Halt
New Message
Please
login
to post a reply